Neogen Statistics
Total Valuation
Neogen has a market cap or net worth of $1.18 billion. The enterprise value is $1.97 billion.
Important Dates
The next estimated earnings date is Thursday, October 9, 2025, before market open.
| Earnings Date | Oct 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Neogen has 217.21 million shares outstanding. The number of shares has increased by 0.19% in one year.
| Current Share Class | 217.21M |
| Shares Outstanding | 217.21M |
| Shares Change (YoY) | +0.19% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 0.34% |
| Owned by Institutions (%) | 108.12% |
| Float | 203.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 22.24 |
| PS Ratio | 1.32 |
| Forward PS | 1.42 |
| PB Ratio | 0.57 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 20.36 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.20 |
| EV / EBITDA | 16.45 |
| EV / EBIT | 5,201.07 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.32, with a Debt / Equity ratio of 0.44.
| Current Ratio | 3.32 |
| Quick Ratio | 1.62 |
| Debt / Equity | 0.44 |
| Debt / EBITDA | 7.21 |
| Debt / FCF | n/a |
| Interest Coverage | 0.01 |
Financial Efficiency
Return on equity (ROE) is -41.88% and return on invested capital (ROIC) is 0.01%.
| Return on Equity (ROE) | -41.88% |
| Return on Assets (ROA) | 0.01% |
| Return on Invested Capital (ROIC) | 0.01% |
| Return on Capital Employed (ROCE) | 0.01% |
| Revenue Per Employee | $300,828 |
| Profits Per Employee | -$367,197 |
| Employee Count | 2,974 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 2.49 |
Taxes
| Income Tax | -41.07M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.65% in the last 52 weeks. The beta is 1.85, so Neogen's price volatility has been higher than the market average.
| Beta (5Y) | 1.85 |
| 52-Week Price Change | -66.65% |
| 50-Day Moving Average | 5.31 |
| 200-Day Moving Average | 7.83 |
| Relative Strength Index (RSI) | 48.44 |
| Average Volume (20 Days) | 5,901,771 |
Short Selling Information
The latest short interest is 18.37 million, so 8.46% of the outstanding shares have been sold short.
| Short Interest | 18.37M |
| Short Previous Month | 17.09M |
| Short % of Shares Out | 8.46% |
| Short % of Float | 9.02% |
| Short Ratio (days to cover) | 3.22 |
Income Statement
In the last 12 months, Neogen had revenue of $894.66 million and -$1.09 billion in losses. Loss per share was -$5.03.
| Revenue | 894.66M |
| Gross Profit | 421.38M |
| Operating Income | 379,000 |
| Pretax Income | n/a |
| Net Income | -1.09B |
| EBITDA | 119.86M |
| EBIT | 379,000 |
| Loss Per Share | -$5.03 |
Full Income StatementBalance Sheet
The company has $129.00 million in cash and $914.27 million in debt, giving a net cash position of -$785.27 million or -$3.62 per share.
| Cash & Cash Equivalents | 129.00M |
| Total Debt | 914.27M |
| Net Cash | -785.27M |
| Net Cash Per Share | -$3.62 |
| Equity (Book Value) | 2.07B |
| Book Value Per Share | 9.54 |
| Working Capital | 402.93M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $58.24 million and capital expenditures -$104.60 million, giving a free cash flow of -$46.35 million.
| Operating Cash Flow | 58.24M |
| Capital Expenditures | -104.60M |
| Free Cash Flow | -46.35M |
| FCF Per Share | -$0.21 |
Full Cash Flow StatementMargins
Gross margin is 47.10%, with operating and profit margins of 0.04% and -122.06%.
| Gross Margin | 47.10% |
| Operating Margin | 0.04% |
| Pretax Margin | -126.65% |
| Profit Margin | -122.06% |
| EBITDA Margin | 13.40% |
| EBIT Margin | 0.04% |
| FCF Margin | n/a |
Dividends & Yields
Neogen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.19% |
| Shareholder Yield | -0.19% |
| Earnings Yield | -92.08% |
| FCF Yield | -3.91% |
Dividend DetailsAnalyst Forecast
The average price target for Neogen is $7.50, which is 37.62% higher than the current price. The consensus rating is "Buy".
| Price Target | $7.50 |
| Price Target Difference | 37.62% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 0.92% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 7, 2021. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 7, 2021 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Neogen has an Altman Z-Score of 1.38 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.38 |
| Piotroski F-Score | 5 |
